PI3 and ovarian carcinoma: In breast and ovarian cancer cell lines, exogenous elafin activated the extracellular signal-regulated kinase (ERK) signaling pathway independent of its protease inhibitory capacity, which resulted in increased tumor cell proliferation and migration [33].